Disc Medicine (IRON) Accounts Payables (2020 - 2026)
Disc Medicine's (IRON) quarterly Accounts Payables came in at $11.8 million in Q1 2026, up 75.43% year-on-year from $6.7 million in Q1 2025, and up 30.39% on a QoQ basis from $9.0 million in Q4 2025.
Disc Medicine (IRON) Accounts Payables (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Accounts Payables data on file, last reported at $11.8 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 75.43% year-over-year to $11.8 million in Q1 2026; TTM through Mar 2026 was $11.8 million, a 75.43% increase from a year earlier, with the FY2025 full-year figure at $9.0 million, up 13.46% from the prior year.
- Accounts Payables for Q1 2026 stood at $11.8 million, up from $9.0 million in the prior quarter.
- Over the last five years, Accounts Payables for IRON reached as high as $16.2 million in Q4 2022 and fell as low as $1.1 million in Q3 2022.
- Historically, Accounts Payables has averaged $7.0 million across 5 years, with a median of $6.4 million in 2025.
- Across the five-year window, Accounts Payables soared 645.92% in 2023 and tumbled 58.18% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $16.2 million in 2022, then retreated by 21.86% to $12.6 million in 2023, then slumped by 37.07% to $7.9 million in 2024, then rose by 13.46% to $9.0 million in 2025, then surged by 30.39% to $11.8 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $11.8 million in Q1 2026, $9.0 million in Q4 2025, and $7.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 11.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.76 Mn |
| Dec 31, 2025 | 9.02 Mn |
| Sep 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 6.35 Mn |
| Mar 31, 2025 | 6.70 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 5.27 Mn |
| Dec 31, 2023 | 12.63 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 5.21 Mn |
| Mar 31, 2023 | 5.64 Mn |
| Dec 31, 2022 | 16.16 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.62 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 939,000.00 |
| Jun 30, 2021 | 1.49 Mn |